The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

Acquired Companies: Roxane Laboratories Inc., Boehringer Ingelheim Vetmedica, Inc., Ben Venue Laboratories, Inc., Actimis Pharmaceuticals